Papers
25
Total Citations
732
H-Index
15
About
Bilal Chughtai is a prominent urologic surgeon and researcher whose work sits at the intersection of minimally invasive surgery, comparative effectiveness research, and urologic oncology. Best known for his rigorous evaluations of robotic-assisted surgical techniques, Chughtai has made substantial contributions to understanding whether the widespread adoption of robotic surgery translates into meaningful clinical and economic benefits for patients. His most-cited work (124 citations) demonstrated that risk-stratified nerve-sparing approaches during robot-assisted radical prostatectomy significantly improve early continence recovery — a finding with direct implications for patient quality of life. Across multiple high-impact studies, he has systematically compared robotic versus open approaches for both prostate and bladder cancer, scrutinizing cancer control, perioperative outcomes, healthcare costs, and long-term survival using large national datasets. His cost-analysis research has been particularly influential in shaping policy conversations around surgical technology adoption. Beyond oncology, Chughtai has emerged as a leading voice on emerging therapies for benign prostatic hyperplasia, including Aquablation and Rezūm, and has investigated safety trends in robotic surgery through FDA adverse event data and litigation analysis. Collectively, his work — spanning over 500 citations — equips clinicians, health systems, and policymakers with evidence to make more informed decisions about surgical innovation.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8Robotic urologic surgery: trends in litigation over the last decade26 citations · 2019
- 9
- 10